Hormone Modulating Therapy (HMT), widely used to treat hormone receptor-positive breast cancer, could offer more than just cancer treatment. It may lower the risk of dementia.
A recent study revealed a 7 per cent reduced risk of Alzheimer's Disease and Related Dementias (ADRD) among breast cancer patients who underwent HMT, although this benefit decreases with age and varies by race.